BRITISH PHARMACOPOEIA 2020 [VERSÃO IMPRESSA]

The British Pharmacopoeia 2020 supersedes the British Pharmacopoeia 2019. It has been prepared by the British Pharmacopoeia Commission, with the collaboration and support of its Expert Advisory Groups, Panels of Experts and Working Parties and contains approximately 4000 monographs for substances, preparations and articles used in the practice of medicine. Some of these monographs are of national origin and have been elaborated or revised under the auspices of the British Pharmacopoeia Commission whilst others (indicated to users by a chaplet of stars) have been elaborated, or revised, under the auspices of the. European Pharmacopoeia Commission, supported by its Groups of Experts and Working Parties, and- are reproduced from the European Pharmacopoeia. This edition, together with its companion volume, the British Pharmacopoeia (Veterinary) 2020, incorporates all the monographs of the 9th Edition of the European Pharmacopoeia, as amended by Supplements 9.1 to 9.8. Users of the British Pharmacopoeia thereby benefit by finding within this comprehensively indexed compendium all current United Kingdom pharmacopoeial standards for medicines for human. use. The BP 2020 comprises six volumes as follows.

SKU 0013180 Category

Descrição

The British Pharmacopoeia (BP) 2020 is the most comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes around 4,000 monographs including the BP (Veterinary) and all European Pharmacopoeia (Ph. Eur.) monographs, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.

  • 35 new BP monographs, 53 new Ph. Eur. monographs
  • 331 amended BP monographs
  • All monographs from the Ph. Eur. 10.0 are included.
  • Concise guide on how to use the BP. Helping you to comply with the BP, navigate more effectively and follow formulated product monographs.
  • Ph. Eur. 10.1 and 10.2 included as in-year online and download product updates.
  • Timeline functionality and cleaner design helps you find the information you need. Easily see updates, withdrawals and omissions of monographs. Archive subscribers can now identify all previous editions of BP and Ph. Eur., through the improved navigation.
  • We’re releasing 16 new BPCRS to coincide with the new and revised monographs in the BP 2020. This means you can order the new chemical reference standards alongside the BP 2020 – helping you comply with the new standards from January 2020.  Browse our BPCRS catalogue

The British Pharmacopoeia Commission has caused this British Pharmacopoeia 2020 to be prepared under regulation 317(1) of the Human Medicines Regulations 2012 and, in accordance with regulation 317(4), the Ministers have arranged for it to be published.

The British Pharmacopoeia 2020 contributes significantly to the quality control of medicinal products for human use. It contains publicly available, legally enforceable standards that provide an authoritative statement of the quality that a product, material or article is expected to meet at any time during its period of use. The Pharmacopoeia! standards are designed to complement and assist the licensing and inspection processes and are part of the overall system for safeguarding the health of purchasers and users of medicinal products in the UK.

The British Pharmacopoeia Commission wishes to record its appreciation of the services of all those who have contributed to this important work.

Volumes I and II Medicinal Substances
Volume III Formulated Preparations: General Monographs

Formulated Preparations: Specific Monographs

Volume IV Herbal Drugs, Herbal Drug Preparations and

Herbal Medicinal Products Materials for use in the Manufacture of Homoeopathic Preparations

Blood-related Products

Immunological Products

Radiopharmaceutical Preparations

Surgical Materials

Volume V Infrared Reference Spectra

Appendices

Supplementary Chapters

Index

Volume VI British Pharmacopoeia (Veterinary) 2020

Members of the British Pharmacopoeia Commission and its supporting Expert Advisory Groups, Panels of Experts and Working Parties are required to comply with a Code of Practice on Declaration of Interests in the Pharmaceutical Industry.

Em Destaque

Produtos Relacionados

Aqui você encontra mais alguns produtos em destaque.